The DOI matches its Crossref record; 111 of the 120 references it cites were found in a registry or an index; 42 of the 153 sources its claims cite were checked for support.
Co-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trials
Open accessAbstract
Co-morbid insomnia and sleep apnea (COMISA) is a highly prevalent and debilitating disorder, which results in additive impairments to patients’ sleep, daytime functioning, and quality of life, and complex diagnostic and treatment decisions for clinicians. Although the presence of COMISA was first recognized by Christian Guilleminault and colleagues in 1973, it received very little research attention for almost three decades, until the publication of two articles in 1999 and 2001 which collectively reported a 30%–50% co-morbid prevalence rate, and re-ignited research interest in the field. Since 1999, there has been an exponential increase in research documenting the high prevalence, common characteristics, treatment complexities, and bi-directional relationships of COMISA. Recent trials indicate that co-morbid insomnia symptoms may be treated with cognitive and behavioral therapy for insomnia, to increase acceptance and use of continuous positive airway pressure therapy. Hence, the treatment of COMISA appears to require nuanced diagnostic considerations, and multi-faceted treatment approaches provided by multi-disciplinary teams of psychologists and physicians. In this narrative review, we present a brief overview of the history of COMISA research, describe the importance of measuring and managing insomnia symptoms in the presence of sleep apnea, discuss important methodological and diagnostic considerations for COMISA, and review several recent randomized controlled trials investigating the combination of CBTi and CPAP therapy. We aim to provide clinicians with pragmatic suggestions and tools to identify, and manage this prevalent COMISA disorder in clinical settings, and discuss future avenues of research to progress the field. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.
Overview
CoChat Summary
TL;DR
COMISA is a common co-morbidity of insomnia and obstructive sleep apnea, associated with worse sleep, daytime functioning, and quality of life than either disorder alone. This narrative review argues that COMISA should be actively screened for and treated with combined CBTi and CPAP, while noting that the best sequencing and measurement approaches still need refinement.
Key findings
- The paper states COMISA prevalence is commonly in the range of 30%–50%; earlier studies reported 43% of 80 insomnia patients had AHI ≥ 5 and 29% had AHI ≥ 15, while 50% of 231 OSA patients reported clinically significant insomnia symptoms.
- A 2010 review cited in the paper concluded 39%–58% of OSA patients report insomnia symptoms, and 29%–67% of insomnia patients meet minimal OSA criteria; a later meta-analysis of 37 studies reported 35% of insomnia patients had AHI ≥ 5, 29% had AHI ≥ 15, and 38% of OSA patients met insomnia criteria.
- The review says COMISA patients have greater impairment in sleep, daytime functioning, depressive/psychiatric symptoms, and quality of life than patients with insomnia or OSA alone, and are also more likely to have reduced CPAP acceptance and use.
- Recent randomized controlled trials reported that CBTi improved insomnia outcomes in COMISA and, in some studies, increased CPAP use by 78 min at 3 months and 48 min at 6 months, or by 61 min at 6 months; another study reported 57 min and 64 min greater CPAP use at 3 and 6 months, respectively.
Methods
- Narrative review of COMISA research, covering prevalence, consequences, measurement issues, treatment approaches, bidirectional mechanisms, and recent randomized controlled trials.
- Synthesizes prior studies and recent RCTs; the text specifically discusses studies of 56, 80, 231, 134, 121, 125, 145, and 630 participants, depending on the cited study.
- Main analytic approach is qualitative synthesis of published evidence rather than a new empirical analysis.
Limitations
- Stated in the paper: there has been a lack of research attention to COMISA for long periods, and there is still a need to validate and refine insomnia measures in the presence of OSA.
- Stated in the paper: the available RCTs give only tentative support for CBTi/CPAP sequencing, and the paper notes that more data are needed to confirm which treatment sequence is best.
- Evident from the text: this is a narrative review, so conclusions depend on heterogeneous prior studies with varying definitions of insomnia, OSA, populations, and outcomes; the paper itself notes that prevalence estimates vary considerably by criteria and sample.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
31 Valid · 2 Not valid · 46 Not checked · 25 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Since this time, a large number of case studies [69], pilot studies [70,71], chart-reviews [65,72], treatment trials [44,49,50], and cluster analyses [41,42] have examined the effect of co-morbid insomnia symptoms on reduced CPAP outcomes in OSA patients.”
§ Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials > 2. Treatment of COMISA > 2.1. Traditional Treatment Approaches
What the sources say
- Partly supportedcites [69] An, 2010, A case of obstructive sleep apnea syndrome presenting as paradoxical insomnia, Psychiatry Investig. sourceExperimental — accuracy not yet measured
The Abstract identifies this as a case report about insomnia symptoms in a patient with obstructive sleep apnea, supporting its citation as a case study. But the Case section says the patient refused CPAP, so the report does not examine whether insomnia reduced CPAP outcomes. (LLM, conf=0.88)
- Not matchedcites [70] Smith, 2009, Sleep onset insomnia is associated with reduced adherence to CPAP therapy, Sleep Biol. Rhythm.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [71] Suraiya, 2006, Sleep onset insomnia in sleep apnea patients: Influence on acceptance of nCPAP treatment, Sleep Med. source
- Disputedcites [65] Philip, P., Bioulac, S., Altena, E., Morin, C.M., Ghorayeb, I., Coste, O., Monteyrol, P.J., and Micoulaud-Franchi, JA. (2018). Specific insomnia symptoms and self-efficacy explain CPAP compliance in a sample of OSAS patients. PLoS ONE, 13. sourceExperimental — accuracy not yet measured
The citation identifies this paper as a treatment trial, but Methods and materials > Participants describes its design as retrospective and cross-sectional. The Discussion also says that no causal inference can be made. Although the paper examines insomnia symptoms and CPAP compliance, it is not a treatment trial. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [72] Wickwire, 2010, Sleep maintenance insomnia complaints predict poor CPAP adherence: A clinical case series, Sleep Med. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“a lack of access to CBTi has resulted in the majority of insomnia sufferers receiving prescriptions for sedative-hypnotic medications as the initial and ongoing treatment [12,13].”
§ Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials > 1. Introduction > 1.1. Insomnia and Obstructive Sleep Apnea
What the sources say
- Partly supportedcites [12] Miller, 2017, Time trends in the family physician management of insomnia: The Australian experience (2000–2015), J. Clin. Sleep Med. sourceExperimental — accuracy not yet measured
The Results (Changes in Management Approaches; page unavailable) report medication use at approximately 90% of Australian family-physician insomnia management occasions. The Introduction describes limited CBT access, but the Discussion says only that unchanged management practices were possibly due to limited health-system capacity. The paper does not establish that lack of CBT access caused most insomnia sufferers to receive sedative-hypnotic prescriptions as both initial and ongoing treatment. (LLM, conf=0.87)
- Partly supportedcites [13] Kaufmann, 2017, Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999–2014, Psychiatr. Serv. sourceExperimental — accuracy not yet measured
The Discussion (page not available) says behavioral treatments for insomnia are much less common than CBT for anxiety, while the Results report that most recorded hypnotic use for sleep problems was medium- or long-term. The paper does not establish that lack of CBT-I access caused prescribing, that most people with insomnia received these medications, or that they received them as initial treatment; it says the reasons for prescribing trends are unclear. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although epidemiological studies provide statistical support for these ‘risk factors’ (e.g., OSA is associated with male gender, increased age, overweight and obesity, snoring, and daytime sleepiness [14])”
§ Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials > 1. Introduction > 1.2. The Beginning of COMISA Research
What the sources say
- Supportedcites [14] Punjabi, 2008, The epidemiology of adult obstructive sleep apnea, Proc. Am. Thor. Soc. source
The Abstract identifies age, male sex, and obesity as factors that increase vulnerability to OSA. It also identifies loud snoring and daytime sleepiness as signs or symptoms that help identify people needing evaluation, supporting the citing sentence’s stated associations. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“For example, questionnaire measures of insomnia commonly include both nocturnal and daytime symptoms [54,55,61].”
§ Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials > 1. Introduction > 1.5. Refining the Measurement of COMISA
What the sources say
- Not checked — no full text of the sourcecites [54] Bastien, 2001, Validation of the insomnia severity index as an outcome measure for insomnia research, Sleep Med. source
- Not checked — no full text of the sourcecites [55] Soldatos, 2000, Athens Insomnia Scale: Validation of an instrument based on ICD-10 criteria, J. Psychosom. Res. source
- Supportedcites [61] Espie, 2014, The Sleep Condition Indicator: A clinical screening tool to evaluate insomnia disorder, BMJ Open source
In Results > Development of the SCI (page not supplied), the paper describes an insomnia questionnaire with items on getting to and remaining asleep and items on daytime functioning and performance. The Discussion (page not supplied) likewise describes sleep pattern and the impact of poor sleep as two components of insomnia assessment. This supports the cited paper as an example of a questionnaire covering both. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, there has previously been a lack of research attention directed toward the validity of existing insomnia measures in the presence of OSA [58].”
§ Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials > 1. Introduction > 1.5. Refining the Measurement of COMISA
What the sources say
- Supportedcites [58] Sweetman, A., Lack, L.C., and McEvoy, D. (2019). Refining the Measurement of Insomnia in Patients with Obstructive Sleep Apnea: Commentary on Wallace and Wohlgemuth. Predictors of Insomnia Severity Index Profiles in US veterans with Obstructive Sleep Apnea. J. Clin. Sleep Med., in press. source
In the commentary’s opening discussion, the authors explicitly describe a “surprising lack of research investigating the validity of current measures of insomnia” when OSA co-occurs. The following discussion also identifies a prior lack of validity data for the Insomnia Severity Index specifically. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
51 more claims · 9 with their cited sources checked
Create a free account to see all 104 claims and to verify the 2 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 41
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The SR concluded that these trials demonstrate the beneficial effects of therapist-administered cognitive behavioral therapy for insomnia (CBTi) on improving insomnia symptoms and increasing CPAP therapy usage.1189”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [1189]
Experimental — accuracy not yet measured
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Bastien, C. (2001) · Sleep Medicine · doi:10.1016/s1389-9457(00)00065-4 · Cited by 8,067 · cited 3×
“For example, questionnaire measures of insomnia commonly include both nocturnal and daytime symptoms [54,55,61].”
BackgroundMethodSelf-citationIncreased Prevalence of Sleep-Disordered Breathing in Adults
Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., & Hla, K. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws342 · Cited by 4,618 · cited 1×
“The prevalence of OSA varies by diagnostic criteria and the sample population, however it is estimated that approximately 10% of the general population fulfil diagnostic criteria for OSA [20].”
BackgroundEpidemiology of insomnia: what we know and what we still need to learn
Ohayon, M. M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0186 · Cited by 3,743 · cited 2×
“The estimated prevalence of insomnia varies widely according to diagnostic criteria and specific populations of interest, however it is thought that 6%–10% of the general population suffer from chronic insomnia disorder, which includes clinically significant and frequent nocturnal sleep disturbances and impaired dayti…”
BackgroundResultAdult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine, Epstein, L. J., Kristo, D., Strollo, P. J., Friedman, N., Malhotra, A., Patil, S. P., Ramar, K., Rogers, R., Schwab, R. J., et al. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27497 · Cited by 3,360 · cited 5×
“Furthermore, as sleep clinics are encouraged to offer educational support for OSA patients commencing CPAP therapy [15], it may be possible to include CBTi interventions within these existing education platforms, to simultaneously target both insomnia symptoms and improved CPAP use [79].”
BackgroundInfluentialThe epidemiology of adult obstructive sleep apnea
Punjabi, N. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-155mg · Cited by 2,361 · cited 2×
“, OSA is associated with male gender, increased age, overweight and obesity, snoring, and daytime sleepiness [14]), reliance on this single profile clearly does not represent all OSA sufferers [26–28].”
BackgroundCPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
McEvoy, R. D., Antic, N. A., Heeley, E., Luo, Y., Ou, Q., Zhang, X., Mediano, O., Chen, R., Drager, L. F., Liu, Z., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606599 · Cited by 2,101 · cited 1×
“The most effective treatment for moderate and severe OSA is continuous positive airway pressure (CPAP) therapy, which stabilizes breathing throughout the night, improves daytime sleepiness and quality of life, and reduces risk of motor-vehicle accidents [15,19,21,22].”
BackgroundQaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965 · cited 1×
“CBTi is the recommended ‘first line’ treatment for insomnia, and appears to be effective in the presence of co-morbid OSA [8,9,52].”
BackgroundClinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943 · cited 1×
“CBTi is the recommended ‘first line’ treatment for insomnia, and appears to be effective in the presence of co-morbid OSA [8,9,52].”
BackgroundAthens Insomnia Scale: Validation of an instrument based on ICD-10 criteria
Soldatos, C. R., Dikeos, D. G., & Paparrigopoulos, T. J. (2000) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(00)00095-7 · Cited by 1,754 · cited 1×
“For example, questionnaire measures of insomnia commonly include both nocturnal and daytime symptoms [54,55,61].”
Background
Research works printed but not linked: 3
- Lichstein, K., McCrae, C., and Wilson, N. (2003). Secondary insomnia: Diagnostic issues, cognitive-behavioral treatment, and future directions. Treating Sleep Disorders: Principles and Practice of Behavioral Sleep Medicine, Wiley.
- Smith, 2009, Sleep onset insomnia is associated with reduced adherence to CPAP therapy, Sleep Biol. Rhythm., 7, 74
- Parikh, 2011, 36 Hours of Sleep Deprivation Reduces Genioglossus Muscle Activity during Hypercapnia and Inspiratory Resistive Loads during Wakefulness, Sleep, 34, A153
Cited by
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Bi-directional relationships between co-morbid insomnia and sleep apnea (COMISA)
Sweetman, A., Lack, L., McEvoy, R. D., Smith, S., Eckert, D. J., Osman, A., Carberry, J. C., Wallace, D., Nguyen, P. D., & Catcheside, P. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101519 · Cited by 203
Self-citationComorbid insomnia and sleep apnoea is associated with all-cause mortality
Lechat, B., Appleton, S., Melaku, Y. A., Hansen, K. L., McEvoy, R. D., Adams, R., CATCHESIDE, P. G., Lack, L. C., Eckert, D. J., & Sweetman, A. (2021) · European Respiratory Journal · doi:10.1183/13993003.01958-2021 · Cited by 176
Self-citationMuehlan, C., Vaillant, C., Zenklusen, I., Kraehenbuehl, S., & Dingemanse, J. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1817380 · Cited by 110
Sweetman, A., Lack, L. C., McEvoy, R. D., Antic, N. A., Smith, S. S., Chai‐Coetzer, C. L., Douglas, J. A., O’Grady, A., Dunn, N., Robinson, J., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00161-2020 · Cited by 78
Self-citation
Metadata
- Authors
- Sweetman, A., Lack, L., & Bastien, C.
- Affiliations
- Flinders University (AU)
- Université Laval (CA)
- Corresponding author
- Sweetman, Alexander
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2019-12-12
- Volume
- 9
- Issue
- 12
- Pages
- 371
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC6956217
- OpenAlex
- W2995714602
- Cited by
- 253
- References
- 120
- Citations by year
- 2026: 46 · 2025: 47 · 2024: 38 · 2023: 47 · 2022: 26 · 2021: 34 · 2020: 13
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Keywords
- insomnia, sleep apnea, comorbidities, prevalence, cognitive behavioral therapy for insomnia, continuous positive airway pressure, CPAP acceptance, sleep quality, daytime functioning, quality of life, diagnosis, interdisciplinary treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Co-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trials. https://app.cochat.ai/papers/10.3390/brainsci9120371
- The paper
- Sweetman, A., Lack, L., & Bastien, C. (2019). Co-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trials. Brain Sciences. https://doi.org/10.3390/brainsci9120371
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
